Our results provide bioinformatics data and experimental evidence that CENPW can be used as a unique biomarker for breast carcinoma, and as a hopeful therapeutic option for the development of related inhibitors to treat breast cancer at the genetic level. This evidence concerns the gene CENPW and breast carcinoma.